Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Verschueren

Showing results (71-80 of 155) with videos related to

Pageof 16
Sort By:
Lupus Science & Medicine|November 28, 2017
Illness representations of systemic lupus erythematosus and systemic sclerosis: a comparison of patients, their rheumatologists and their general practitionersSeher Arat, Jan L Lenaerts, Ellen De Langhe, et al.
Rheumatology (Oxford, England)|November 28, 2019
Fulminant macrophage activation syndrome in a patient with anti-synthetase syndromeFriedel Vulsteke, Jean-Baptiste Vulsteke, Tim Balthazar, et al.
Rheumatology (Oxford, England)|January 12, 2021
Having a co-morbidity predicts worse outcome in early rheumatoid arthritis despite intensive treatment: a post hoc evaluation of the pragmatic randomized controlled CareRA trialVeerle Stouten, René Westhovens, Diederik De Cock, et al.
Trials|October 29, 2023
Effectiveness and feasibility of a mobile health self-management intervention in rheumatoid arthritis: study protocol for a pragmatic multicentre randomised controlled trial (AEGORA)Michaël Doumen, Elias De Meyst, Cedric Lefevre, et al.
Connective Tissue Research|April 7, 2016
Serum of patients with active rheumatoid arthritis inhibits differentiation of osteochondrogenic precursor cellsJanak L Pathak, Patrick Verschueren, Willem F Lems, et al.
Calcified Tissue International|May 14, 2015
Mechanical loading reduces inflammation-induced human osteocyte-to-osteoclast communicationJanak L Pathak, N Bravenboer, Frank P Luyten, et al.
Calcified Tissue International|February 19, 2016
Systemic Inflammation Affects Human Osteocyte-Specific Protein and Cytokine ExpressionJanak L Pathak, Astrid D Bakker, Frank P Luyten, et al.
Rheumatology (Oxford, England)|November 22, 2024
A mobile app to support self-management and remotely monitor disease impact in rheumatoid arthritis: the randomized controlled AEGORA trialMichaël Doumen, Elias De Meyst, Delphine Bertrand, et al.
Plos One|June 24, 2015
CXCL8 and CCL20 Enhance Osteoclastogenesis via Modulation of Cytokine Production by Human Primary OsteoblastsJanak L Pathak, Astrid D Bakker, Patrick Verschueren, et al.
Annals of the Rheumatic Diseases|July 1, 2021
Response to: 'Correspondence on 'Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial'' by Jain and Dhir <i>et al</i>Veerle Stouten, René Westhovens, Sofia Pazmino, et al.
Pageof 16

Showing results (71-80 of 155) with videos related to

Sort By:
Pageof 16
Lupus Science & Medicine|November 28, 2017
Illness representations of systemic lupus erythematosus and systemic sclerosis: a comparison of patients, their rheumatologists and their general practitionersSeher Arat, Jan L Lenaerts, Ellen De Langhe, et al.
Rheumatology (Oxford, England)|November 28, 2019
Fulminant macrophage activation syndrome in a patient with anti-synthetase syndromeFriedel Vulsteke, Jean-Baptiste Vulsteke, Tim Balthazar, et al.
Rheumatology (Oxford, England)|January 12, 2021
Having a co-morbidity predicts worse outcome in early rheumatoid arthritis despite intensive treatment: a post hoc evaluation of the pragmatic randomized controlled CareRA trialVeerle Stouten, René Westhovens, Diederik De Cock, et al.
Trials|October 29, 2023
Effectiveness and feasibility of a mobile health self-management intervention in rheumatoid arthritis: study protocol for a pragmatic multicentre randomised controlled trial (AEGORA)Michaël Doumen, Elias De Meyst, Cedric Lefevre, et al.
Connective Tissue Research|April 7, 2016
Serum of patients with active rheumatoid arthritis inhibits differentiation of osteochondrogenic precursor cellsJanak L Pathak, Patrick Verschueren, Willem F Lems, et al.
Calcified Tissue International|May 14, 2015
Mechanical loading reduces inflammation-induced human osteocyte-to-osteoclast communicationJanak L Pathak, N Bravenboer, Frank P Luyten, et al.
Calcified Tissue International|February 19, 2016
Systemic Inflammation Affects Human Osteocyte-Specific Protein and Cytokine ExpressionJanak L Pathak, Astrid D Bakker, Frank P Luyten, et al.
Rheumatology (Oxford, England)|November 22, 2024
A mobile app to support self-management and remotely monitor disease impact in rheumatoid arthritis: the randomized controlled AEGORA trialMichaël Doumen, Elias De Meyst, Delphine Bertrand, et al.
Plos One|June 24, 2015
CXCL8 and CCL20 Enhance Osteoclastogenesis via Modulation of Cytokine Production by Human Primary OsteoblastsJanak L Pathak, Astrid D Bakker, Patrick Verschueren, et al.
Annals of the Rheumatic Diseases|July 1, 2021
Response to: 'Correspondence on 'Five-year treat-to-target outcomes after methotrexate induction therapy with or without other csDMARDs and temporary glucocorticoids for rheumatoid arthritis in the CareRA trial'' by Jain and Dhir <i>et al</i>Veerle Stouten, René Westhovens, Sofia Pazmino, et al.
Pageof 16